ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MOHAMMAD HAQUE M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,087Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 4623

$1.13M Total Retail Price of All Prescriptions

Rank: 105 out of 4623

691 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

31% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,599 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 882 467 S3 1 3
FUROSEMIDE 543 437 2 8
LEVOTHYROXINE SODIUM 531 456 3 1
AMLODIPINE BESYLATE 494 420 4 5
SIMVASTATIN 426 354 5 2
TRAMADOL HCL 363 240 6 15
METOPROLOL TARTRATE 358 243 7 9
LISINOPRIL 336 289 8 4
WARFARIN SODIUM 326 253 9 24
OMEPRAZOLE 317 241 10 7
DONEPEZIL HCL 311 302 11 30
METFORMIN HCL 301 226 12 6
POTASSIUM CHLORIDE 281 217 13 14
RISPERIDONE 254 216 14 72
QUETIAPINE FUMARATE 241 204 15 74
CLONIDINE HCL 225 179 16 40
MIRTAZAPINE 225 192 16 57
GABAPENTIN 218 145 18 16
NAMENDA 216 205 19 36
MELOXICAM 209 138 20 27
SERTRALINE HCL 204 179 21 26
EXELON 196 181 22 107
ZOLPIDEM TARTRATE 193 94 23 18
TRAZODONE HCL 181 130 24 42
CLOPIDOGREL 180 134 25 31
CYMBALTA 179 112 26 48
DIVALPROEX SODIUM 171 133 27 90
LYRICA 170 100 28 66
TAMSULOSIN HCL 165 150 29 29
GENTAMICIN SULFATE 157 113 30 278
ESCITALOPRAM OXALATE 156 128 31 75
PANTOPRAZOLE SODIUM 151 125 32 35
METOPROLOL SUCCINATE 151 136 32 13
NEXIUM 134 90 34 17
CARVEDILOL 120 100 35 25
CITALOPRAM HBR 118 102 36 23
DIOVAN 111 90 37 39
DIGOXIN 111 98 37 58
PLAVIX 110 88 39 45
ATORVASTATIN CALCIUM 109 100 40 12
FAMOTIDINE 107 60 41 82
POLYETHYLENE GLYCOL 3350 103 65 42 91
CRESTOR 100 42 43 20
NOVOLOG 97 75 44 123
NOVOLOG FLEXPEN 95 91 45 206
LOSARTAN POTASSIUM 95 75 45 21
LEVEMIR 93 76 47 154
SANTYL 93 82 47 213
LEVOFLOXACIN 92 69 49 81
CIPROFLOXACIN HCL 90 70 50 43
ATENOLOL 88 86 51 28
PREDNISONE 86 60 52 50
NIFEDIPINE ER 86 80 52 97
ALLOPURINOL 84 76 54 37
LEVETIRACETAM 83 49 55 114
SEROQUEL 82 74 56 149
HYDRALAZINE HCL 82 77 56 99
PHENYTOIN SODIUM EXTENDED 82 41 56 119
HYDROCHLOROTHIAZIDE 80 58 59 10
CYCLOBENZAPRINE HCL 72 20 R 60 53
METHOCARBAMOL 71 31 R 61 155
NYSTATIN 68 50 62 175
ALBUTEROL SULFATE 67 47 63 142
ENALAPRIL MALEATE 65 41 64 41
GLYBURIDE-METFORMIN HCL 63 48 R 65 56
NITROFURANTOIN MONO-MACRO 63 52 65 172
KLOR-CON M20 62 46 67 102
AZITHROMYCIN 62 44 67 33
NOVOLIN R 62 57 67 113
IPRATROPIUM BROMIDE 60 44 70 216
SYMBICORT 60 42 70 151
FLUTICASONE PROPIONATE 59 43 72 32
GLIPIZIDE 58 58 73 49
OXYBUTYNIN CHLORIDE 58 42 73 120
TRIAMCINOLONE ACETONIDE 57 40 75 124
PRAVASTATIN SODIUM 57 42 75 11
NITROGLYCERIN PATCH 56 54 77 190
RAMIPRIL 56 35 77 76
HUMALOG 55 30 79 186
TRICOR 52 31 80 88
CLINDAMYCIN HCL 52 22 80 236
BACLOFEN 52 25 80 133
AMOX TR-POTASSIUM CLAVULANATE 51 29 83 117
LEVEMIR FLEXPEN 51 45 83 167
ALENDRONATE SODIUM 51 45 83 22
OXYBUTYNIN CHLORIDE ER 51 48 83 163
GLIMEPIRIDE 51 51 83 38
VALPROIC ACID 50 19 88 229
CELEBREX 50 46 88 89
LIDODERM 50 32 88 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.